Reflex, Abnormal clinical trials
The registry lists 18 studies for Reflex, Abnormal across more than 10 countries. 1 are recruiting or about to start. 8 of them are mainly about Reflex, Abnormal (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-13.
Get an email when these change. Save the Reflex, Abnormal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Istanbul Physical Medicine Rehabilitation Training and Research Hospital (4) · TC Erciyes University (2) · Watson Pharmaceuticals (2) · Hospices Civils de Lyon (1) · Johns Hopkins University (1) · Burke Medical Research Institute (1) · Wake Forest University Health Sciences (1) · Cairo University (1)
What is being tested here
Drugs under test in Reflex, Abnormal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Hyaluronoglucosaminidase | 0 | 0 | 1 |
| Dexmedetomidine | 0 | 0 | 1 |
| Esmolol | 0 | 0 | 1 |
Who these studies take
Of the 1 Reflex, Abnormal studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 18 studies, recruiting or not: 67% stop at 75 or younger and 56% at 65; 17% take children; 0% are for women only and 0% for men only; 39% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 18 of 18. search them.
- Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral PalsyRecruitingNCT05571033Not applicable1 country
- High-power Laser Versus Pulsed Electromagnetic Therapy in Lumbar Radiculopathy.CompletedNCT07393750Not applicable1 country
- Peripheral Modulation of Muscle Stiffness and SpasticityActive, not recruitingNCT03306615Phase 21 country
- Validation of a Spasticity Measurement ToolActive, not recruitingNCT053741741 country
- Covert Saccade Triggers in Bilateral Vestibular HypofunctionCompletedNCT04268615Not applicable1 country
- Neuromodulation in Lower Limb AmputeesTerminatedNCT04543786Not applicable1 country
- Biomarker for Duchenne Muscular DystrophyCompletedNCT029940308 countries
- The Diagnostic Role of Adding the Hoffman Reflex Study for L5 Radiculopathy in the Electrodiagnostic LaboratoryCompletedNCT052696021 country
- Reliability of Methods for Determining the Vibration ThresholdCompletedNCT05129982Not applicable1 country
- Determination of Onset Point of Mechanical StimulationCompletedNCT04347083Not applicable1 country
- The Reflex Mechanism Underlying Neuromuscular Effects Of The Whole Body VibrationCompletedNCT04516798Not applicable1 country
- Prepulse Inhibition in Youth Contact Sports PlayersCompletedNCT040581841 country
- Optimal Interstimulus Interval For Consecutive H-Reflex Responses In Patients With SpasticityCompletedNCT04005937Not applicable1 country
- Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)TerminatedNCT02090725Phase 21 country
- Long-term Surveillance of the MedStream Programmable Infusion SystemTerminatedNCT017120871 country
- The Effects of the Drugs Used in Hypotensive Anaesthesia on CochleaCompletedNCT02062333Phase 41 country
- Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological ConditionCompletedNCT00224016Phase 41 country
- A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological ConditionCompletedNCT00224029Phase 41 country